BARDA Makes $26 Million Purchase Of Monkeypox Drug Tecovirimat

By Jessica Karins / August 10, 2022 at 2:33 PM
HHS is increasing its supply of the drug tecovirimat, or TPOXX, by purchasing a supply of the approved smallpox and experimental monkeypox treatment’s intravenous formulation from its manufacturer. The purchase will supply the federal government’s Strategic National Stockpile with an alternative to the drug’s pill format. An official at the Office of the Assistant Secretary for Preparedness and Response told Inside Health Policy the purchase was planned in advance as part of smallpox preparedness efforts and is not in...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.